MMP9 and ischemic stroke: Preclinical animal studies suggest that MMP-9 inhibition can be of therapeutic importance in ischemic stroke although a small pilot study conducted in humans did not show efficacy of this drug on 3-months mRS score in the setting of IV thrombolysis (28–33).